A 2017 Pharma Serialisation Readiness Report focusing on industry readiness for the EU FMD deadlines, conducted by GS1 Ireland and ESP

UDG Healthcare ‘Track and Trace’ Immunisation Pilot Report Supports Case for National Roll Out of Vaccine Tracking (Feb 2014)

Serialisation and Product Verification - A Joint Position Paper from EFPIA IFPMA PhRMA to Help to Secure the Legal Supply Chain for Greater Patient Safety (Nov 2013)

In a recently published shared vision for product identification, the European Federation of Pharmaceutical Industries and Associations (EFPIA) supports the use of GS1 standards for the identification of products.

Obama signs H.R. 3204 into law, setting the wheels in motion for the FDA to develop a national track-and-trace system for medicines.

Advice and training from GS1 experts on implementing GS1 identification, barcoding and labelling standards such as GTINs, AIs and Data Matric Symbols for global serialisation requirements such as the EU falsified Medicines Directive (FMD).

Delegated Acts on safety features in the EU Falsified Medicines Directive (FMD) have been published and a compliance date set.

Draft directive issued for a unique identifier and an anti-tampering safety feature to prevent falsified medicine in the supply chain in Europe